Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 9743280, 17 pages
https://doi.org/10.1155/2017/9743280
Research Article

NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats

Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China

Correspondence should be addressed to Zhong-yuan Xia; moc.nuyila@5002nauygnohzaix

Received 17 April 2017; Revised 22 June 2017; Accepted 17 August 2017; Published 14 September 2017

Academic Editor: Hong Zheng

Copyright © 2017 Zhen Qiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Badalzadeh, B. Mokhtari, and R. Yavari, “Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus,” The Journal of Physiological Sciences, vol. 65, no. 3, pp. 201–215, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. H. K. Eltzschig and T. Eckle, “Ischemia and reperfusion—from mechanism to translation,” Nature Medicine, vol. 17, no. 11, pp. 1391–1401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Balakumar and N. K. Sharma, “Healing the diabetic heart: does myocardial preconditioning work?” Cellular Signalling, vol. 24, no. 1, pp. 53–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Przyklenk, M. Maynard, D. L. Greiner, and P. Whittaker, “Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes,” Antioxidants & Redox Signaling, vol. 14, no. 5, pp. 781–790, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Minutoli, D. Puzzolo, M. Rinaldi et al., “ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia/reperfusion injury,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 2183026, 10 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Ansley and B. Wang, “Oxidative stress and myocardial injury in the diabetic heart,” The Journal of Pathology, vol. 229, no. 2, pp. 232–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ding, J. Lei, H. Han et al., “SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats,” Cardiovascular Diabetology, vol. 14, pp. 143–154, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. T. S. Devi, I. Lee, M. Hüttemann, A. Kumar, K. D. Nantwi, and L. P. Singh, “TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy,” Experimental Diabetes Research, vol. 2012, Article ID 438238, 19 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Harijith, D. L. Ebenezer, and V. Natarajan, “Reactive oxygen species at the crossroads of inflammasome and inflammation,” Frontiers in Physiology, vol. 5, pp. 352–362, 2014. View at Publisher · View at Google Scholar
  10. M. Lamkanfi and V. M. Dixit, “Inflammasomes and their role in health and disease,” Annual Review of Cell and Developmental Biology, vol. 28, pp. 137–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Strowig, J. Henao-Mejia, E. Elinav, and R. Flavell, “Inflammasomes in health and disease,” Nature, vol. 481, no. 7381, pp. 278–286, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. G. V. Paramel, A. Sirsjö, and K. Fransén, “Role of genetic alterations in the NLRP3 and CARD8 genes in health and disease,” Mediators of Inflammation, vol. 2015, Article ID 846782, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Aachoui, V. Sagulenko, E. A. Miao, and K. J. Stacey, “Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection,” Current Opinion Microbiology, vol. 16, no. 3, pp. 319–326, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Schroder and J. Tschopp, “The inflammasomes,” Cell, vol. 140, no. 6, pp. 821–832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Broz, “Inflammasomes: intracellular detection of extracellular bacteria,” Cell Research, vol. 28, no. 8, pp. 859-860, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Broz and V. M. Dixit, “Inflammasomes: mechanism of assembly, regulation and signalling,” Nature Reviews. Immunology, vol. 16, no. 7, pp. 407–420, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Horng, “Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome,” Trends in Immunology, vol. 35, no. 6, pp. 253–261, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Ratsimandresy, A. Dorfleutner, and C. Stehlik, “An update on PYRIN domain-containing pattern recognition receptors: from immunity to pathology,” Frontiers in Immunology, vol. 4, article 440, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Dinarello, “Immunological and inflammatory functions of the interleukin-1 family,” Annual Review of Immunology, vol. 27, pp. 519–550, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Chen, M. R. Smith, K. Thirumalai, and A. Zychlinsky, “A bacterial invasin induces macrophage apoptosis by binding directly to ICE,” The EMBO Journal, vol. 15, no. 15, pp. 3853–3860, 1996. View at Google Scholar
  21. J. Yu, H. Nagasu, and T. Murakami, “Inflammasome activation leads to caspase-1-dependent mitochondrial damage and block of mitophagy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 43, pp. 15514–15522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Danelishvili and L. E. Bermudez, “Analysis of pyroptosis in bacterial infection,” Methods in Molecular Biology, vol. 1004, pp. 67–73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Chang, J. Lin, J. Dong, and D. Li, “Pyroptosis: an inflammatory cell death implicates in atherosclerosis,” Medical Hypotheses, vol. 81, no. 3, pp. 484–486, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Li, N. Du, Q. Zhang et al., “MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy,” Cell Death & Disease, vol. 5, article e1479, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. S. Tan, L. Tan, T. Jiang et al., “Amyloid-β induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer’s disease,” Cell Death & Disease, vol. 5, article e1382, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Takahashi, “NLRP3 in myocardial ischaemia-reperfusion injury: inflammasome-dependent or -independent rolein different cell types,” Cardiovascular Research, vol. 99, no. 1, pp. 4-5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. Ø. Sandanger, T. Ranheim, L. E. Vinge et al., “A role for NLRP3 inflammasome in acute myocardial ischaemia-reperfusion injury? Reply,” Cardiovascular Research, vol. 99, no. 1, pp. 226-227, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. Ø. Sandanger, T. Ranheim, and L. E. Vinge, “The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury,” Cardiovascular Research, vol. 99, no. 1, pp. 164–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Luo, B. Li, W. Wang et al., “NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model,” PLoS One, vol. 9, no. 8, article e104771, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Giordano, I. Murano, E. Mondini et al., “Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis,” Journal of Lipid Research, vol. 54, no. 9, article 23836106, pp. 2423–2436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Liu, K. Lian, L. Zhang et al., “TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury,” Basic Research in Cardiology, vol. 109, no. 5, pp. 415–428, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Zhang, J. H. Zhang, X. Y. Chen et al., “Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation,” Antioxidants & Redox Signaling, vol. 22, no. 10, pp. 848–870, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Xue, S. Lei, Z. Y. Xia et al., “Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways,” Clinical Science, vol. 130, no. 5, pp. 377–392, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Liu, B. Zhou, Z. Y. Xia et al., “Hyperglycemia-induced inhibition of DJ-1 expression compromised the effectiveness of ischemic postconditioning cardioprotection in rats,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 564902, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Min, Z. W. Bin, Z. B. Quan, Z. J. Hui, and F. G. Sheng, “The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats,” Cardiovascular Diabetology, vol. 8, no. 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. C. M. Yang, I. T. Lee, R. C. Hsu, P. L. Chi, and L. D. Hsiao, “NADPH oxidase/ROS-dependent PYK2 activation is involved in TNF-α-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells,” Toxicology and Applied Pharmacology, vol. 272, no. 2, pp. 431–442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. S. Kim, J. S. Kim, J. S. Kwon et al., “BAY 11-7082, a nuclear factor-κB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model,” International Heart Journal, vol. 51, no. 5, pp. 348–353, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Lu, B. Wang, S. Zhong et al., “N-n-Butyl haloperidol iodide ameliorates hypoxia/reoxygenation injury through modulating the LKB1/AMPK/ROS pathway in cardiac microvascular endothelial cells,” Oncotarget, vol. 7, no. 23, pp. 34800–34810, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Zhang, H. Liao, S. Zhong et al., “Effect of N-n-butyl haloperidol iodide on ROS/JNK/Egr-1 signaling in H9c2 cells after hypoxia/reoxygenation,” Scientific Reports, vol. 5, article 11809, 2015. View at Publisher · View at Google Scholar
  40. F. M. Marim, M. M. Franco, M. T. Gomes, M. C. Miraglia, G. H. Giambartolomei, and S. C. Oliveira, “The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection,” Seminars in Immunopathology, vol. 39, no. 2, pp. 215–223, 2017. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Abe and C. Morrell, “Pyroptosis as a regulated form of necrosis: PI+/annexin V−/high caspase 1/low caspase 9 activity in cells = pyroptosis?” Circulation Research, vol. 118, no. 10, pp. 1457–1460, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Li, Z. Liu, J. Wang et al., “Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats,” Cardiovascular Diabetology, vol. 12, pp. 133–143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Li, Y. Bian, N. Zhang et al., “Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats,” Cardiovascular Diabetology, vol. 12, pp. 91–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Ghaboura, S. Tamareille, P. H. Ducluzeau et al., “Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling,” Basic Research in Cardiology, vol. 106, no. 1, pp. 147–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Arslan, M. B. Smeets, L. A. O'Neill et al., “Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody,” Circulation, vol. 121, no. 1, pp. 80–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. L. Fink and B. T. Cookson, “Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells,” Infection and Immunity, vol. 73, no. 4, pp. 1907–1916, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Zheng, S. E. Gardner, and M. C. Clarke, “Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 12, pp. 2781–2786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Hu, R. Ma, J. Lu et al., “IL-23 promotes myocardial I/R injury by increasing the inflammatory responses and oxidative stress reactions,” Cellular Physiology and Biochemistry, vol. 38, no. 6, pp. 2163–2172, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Steffens, F. Montecucco, and F. Mach, “The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury,” Thrombosis and Haemostasis, vol. 102, no. 2, pp. 240–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Takahashi, “NLRP3 inflammasome as a novel player in myocardial infarction,” International Heart Journal, vol. 55, no. 2, pp. 101–105, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Sharma and T. D. Kanneganti, “The cell biology of inflammasomes: mechanisms of inflammasome activation and regulation,” The Journal of Cell Biology, vol. 213, no. 6, pp. 617–629, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. F. S. Sutterwala, S. Haasken, and S. L. Cassel, “Mechanism of NLRP3 inflammasome activation,” Annals of the New York Academy of Sciences, vol. 1319, no. 1, pp. 82–95, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Doitsh, N. L. Galloway, X. Geng et al., “Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection,” Nature, vol. 505, no. 7484, pp. 509–514, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. S. L. Fink and B. T. Cookson, “Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages,” Cellular Microbiology, vol. 8, no. 11, pp. 1812–1825, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Lamkanfi and V. M. Dixit, “Manipulation of host cell death pathways during microbial infections,” Cell Host & Microbe, vol. 8, no. 1, pp. 44–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. M. M. Gaidt and V. Hornung, “Pore formation by GSDMD is the effector mechanism of pyroptosis,” The EMBO Journal, vol. 35, no. 20, pp. 2167–2169, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. J. R. Yang, F. H. Yao, J. G. Zhang et al., “Ischemia-reperfusion induces renal tubule pyroptosis via the CHOP-caspase-11 pathway,” American Journal of Physiology-Renal Physiology, vol. 306, no. 1, pp. F75–F84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Kovarova, P. R. Hesker, L. Jania et al., “NLRP1 dependent pyroptosis leads to acute lung injury and morbidity in mice,” Journal of Immunology, vol. 189, no. 4, pp. 2006–2016, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Juliana, T. Fernandes-Alnemri, J. Wu et al., “Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome,” The Journal of Biological Chemistry, vol. 285, no. 13, pp. 9792–9802, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Irrera, M. Vaccaro, A. Bitto et al., “BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis,” Clinical Science, vol. 131, no. 6, pp. 487–498, 2017. View at Publisher · View at Google Scholar